Under section 41JM of the Act, as prescribed in Part 8AA (added by the UDI and Other Measures Regulations 2025, commenced 21 March 2026), the chief executive of a healthcare facility (including a day-hospital facility) must report adverse events involving reportable medical devices, namely Class III devices and Class 4 IVDs. The report must include the facility's healthcare identifier, the date of use and the date of death or of first identifying the serious deterioration with its nature, the date of any intervention or treatment and the nature of the deterioration, and the manufacturer's name if known. It must be given within 10 days of the death or of identifying the deterioration, or within 45 days of the intervention or treatment, in an electronic form (not fax or a scanned document).
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.